Skip to content
CLB

Core Laboratories Inc. /DE/

Core Laboratories Inc. /DE/ Q4 FY2024 earnings call

January 30, 2025 · fiscal period ended 2024-12

EPS · actual vs est

— / —

Revenue · actual vs est

— / —
Ask about this call

Summary

Generated 2025-01-30

Management highlights

Core continued to execute its strategic plan of technology investments. In Reservoir Description, despite geopolitical headwinds, there was strong market demand for global rock and fluid laboratory services with ex-items operating margins remaining strong. Production Enhancement saw revenue declines but had higher international product sales and growth in completion diagnostic services. Operational highlights included Reservoir Description assisting a Middle East offshore operator with produced water reinjection and Production Enhancement working on refrac energetic technologies and completion diagnostics for a Gulf of Mexico operator.

View in transcript ↓

Segment performance

Reservoir Description: Fourth quarter 2024 revenue was $86.8 million, down 2% compared to Q3 2024 but up 3% from Q4 2023. Ex-items operating margin was 16% in Q4, down sequentially by 110 basis points but up year-over-year by 170 basis points. Production Enhancement: Fourth quarter 2024 revenue was $42.4 million, down 7% sequentially from Q3 2024 and roughly flat for full-year 2024 versus 2023. Ex-items operating margin in Q4 2024 was 4%.

View in transcript ↓

Guidance

For Q1 2025, Reservoir Description revenue is projected to range from $82 million to $85 million with operating income of $9 million to $10.7 million. Production Enhancement revenue is expected to range from $39 million to $42 million with operating income of $1.1 million to $2 million. The company's effective tax rate is projected at approximately 25% for 2025, and Q1 2025 EPS is expected to range from $0.12 to $0.16.

View in transcript ↓

Risks

Geopolitical conflicts and sanctions are producing headwinds to revenue growth and operating margins for Reservoir Description. Completion Diagnostic services scheduled for 2024 in the Gulf of Mexico were delayed by hurricanes. Volatility in crude oil prices and expanded sanctions are causing disruptions to crude assay laboratory services.

View in transcript ↓

Q&A highlights

Q: Stephen Gengaro asked about competitive dynamics and pricing in Production Enhancement's US market.

A: Larry Bruno noted it's a crowded market with stable pricing but competition, and they aim for technology advantages to differentiate.

Q: Josh Jayne asked about international market growth and Q1 weather impact.

A: Larry Bruno discussed growth in Middle East, South Atlantic, etc., and Q1 weather-related closures led to about $1 million in lost revenue with high incrementals.

Q: David Smith asked about geopolitical disruptions impact on Reservoir Description margins.

A: Larry Bruno acknowledged sanctions impacting margins, with expansion of sanctions having immediate impact on both segments.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS————
Revenue————

Transcript

January 30, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.